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Aims To evaluate the accuracy of low-dose computed tomography coronary angiography (CTCA) using prospective ECG-
triggering for the assessment of coronary artery disease (CAD).
Methods
and results
A total of 30 patients (19 males, 11 females, mean age 58.8+ 9.9 years) underwent low-dose CTCA and invasive
coronary angiography (CA) [median 2 days (0, 41)]. Before CT scanning, intravenous beta-blocker was administered
in 18 of 30 patients as heart rate (HR) was .65 b.p.m., achieving a mean HR of 55.7+7.9 b.p.m. CAD was defined as
coronary artery narrowing 50%, using CA as standard of reference. The estimated mean effective radiation dose
was 2.1+ 0.7 mSv (range: 1.0–3.3), yielding 96.0% (383/399) of evaluable segments. On an intention-to-diagnose-
base, all non-evaluative segments were included in the analysis. Vessels with a non-evaluative segment and no
further finding were censored as false positive. Patient-based analysis revealed sensitivity, specificity, positive predic-
tive value, and negative predictive value of 100, 83.3, 90.0, and 100%, respectively. The respective values per vessel
were 100, 88.9, 85.7, and 100%, respectively.
Conclusion Prospective ECG-triggering allows low-dose CTCA and provides high diagnostic accuracy in the assessment of CAD
in patients with stable sinus rhythm and a low heart rate.
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Introduction
The implementation of 64-multidetector computed tomography
(CT) has been a milestone for the introduction of CT coronary
angiography (CTCA) as diagnostic tool for non-invasive assess-
ment of coronary artery stenoses in the clinical routine.1–7
Throughout all technical advances, the two main challenges still
remain motion-free depiction of coronary arteries and reduction
of radiation exposure to the patient. Although new developments
such as dual-source technology8–14 and latest scanner generations
with 25615 and more slices16 may help reducing motion artefacts,
the issue of radiation is not solved by these technical advances. In
fact, in a preliminary study using 256 slices, radiation administered
to the patient has been reported as high as 33 mSv.15 In view of
the ongoing debate on the radiation burden of CTCA and its
risk of cancer induction,17 any suggestion to successfully reduce
radiation dose is important. Introduction of tube modulation by
electrocardiogram has reduced radiation from over 20 mSv4 to
10–15 mSv,2 and optimized protocols have achieved doses as
low as ,8 mSv.18
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Themost promising approach for dose reduction seems to be the
use of a new scanning protocol applying prospective ECG triggering,
where radiation is administered only at one predefined end-diastolic
time point instead of during a whole phase of the cardiac cycle.19
A recent report has demonstrated the clinical feasibility of such
low-dose CTCA with prospective triggering to achieve diagnostic
image quality despite reduction of radiation dose by almost an
order of magnitude.20 However, no data on the accuracy of
CTCA by prospective triggering compared with invasive CA are
available so far.
Thus, the purpose of our study was to investigate the accuracy
of low-dose CTCA using prospective ECG triggering for the
assessment of coronary stenoses in comparison with invasive CA.
Methods
Study population
The present study evaluated patients with suspected chronic stable
coronary artery disease (CAD). We decided to aim at including 30
patients into the final analysis of this preliminary report, although no
formal sample size calculation was performed due to the pilot
nature of this study. Among 112 consecutive patients referred for elec-
tive invasive CA, 70 patients deemed ineligible due to known significant
CAD. Four of the remaining 42 patients refused to give the consent
and eight were excluded due to allergy to iodinated contrast agent
(n ¼ 1), nephropathy (creatinine levels .150 mmol/L or .1.7 mg/
dL) (n ¼ 4), non-sinus rhythm, known premature ventricular, or supra-
ventricular beats (n ¼ 3). The 30 patients included in our final analysis
were referred for the following symptoms: dyspnoea (n ¼ 3), typical
angina pectoris (n ¼ 9), atypical chest pain (n ¼ 10), pathological exer-
cise test, or ECG (n ¼ 11). All patients underwent both invasive CA
and CTCA. The study protocol was approved by the local ethics com-
mittee and written informed consent was obtained from patients
included in the study.
Data acquisition and post-processing
All patients received a single dose of 2.5 mg isosorbiddinitrate sublin-
gual (Isoket, Schwarz Pharma, Monheim, Germany) 2 min prior to
the scan. In addition, intravenous metoprolol (2–20 mg) (Beloc,
AstraZeneca, London, UK) was administered, if necessary to achieve
a target HR of ,65 b.p.m. prior to the start of the scan. The HR
was monitored and HR variability was assessed as the standard
deviation of the HR throughout the scan as reported previously.21
For CTCA, 80 mL of iodixanol (Visipaque 320, 320 mg/mL, GE Heath-
care, Buckinghamshire, UK) at a flow rate of 5 mL/s followed by 50 mL
saline solution was injected into an antecubital vein through an
18-gauge catheter. Bolus tracking was performed with a region of
interest placed into the ascending aorta, and image acquisition
was started 4 s after the signal density reached a threshold of 120
Hounsfield units (HU).
All CTCA examinations were performed with a LightSpeed VCT XT
scanner (GE Healthcare) and prospective ECG triggering,19 using a
commercially available protocol (SnapShot Pulse, GE Healthcare)
and the following scanning parameters as previously reported:20 slice
acquisition acquisition 64  0.625 mm, smallest X-ray window (only
75% of the RR-cycle), z-coverage 40 mm with an increment of
35 mm, gantry rotation time 350 ms, body mass index (BMI) adapted
tube voltage (100 kV: BMI ,25 kg/m2; 120 kV: BMI 25 kg/m2) and
effective tube-current (450 mA: BMI ,22.5 kg/m2; 500 mA: BMI
22.5–25 kg/m2; 550 mA: BMI 25–27.5 kg/m2; 600 mA: BMI
27.5–30 kg/m2; 650 mA: BMI .30 kg/m2). The CT scan was per-
formed from below the tracheal bifurcation to the diaphragm, choos-
ing three to four scan blocks (field of view 11–14.5 cm). By restricting
the scan to the smallest possible window at only one distinct end-
diastolic phase of the RR-cycle (i.e. 75%), we ascertained the lowest
achievable effective dose delivery.
The effective dose from CTCA was calculated as the product of
the dose-length product (DLP) times a conversion coefficient for
the chest (k ¼ 0.017 mSv/mGy cm) as previously suggested.22 The
CTCA images were reconstructed with a slice thickness of 0.6 mm,
using a medium-soft tissue convolution kernel (standard). In case of
vessel wall calcifications, additional images were reconstructed using
a sharp-tissue convolution kernel (detail) and preferably analysed
using a bone window setting (window width: 1500 HU; window
level: 500 HU) to compensate for blooming artefacts. All images
were transferred to an external workstation (AW 4.4, GE Healthcare).
Computed tomography image analysis
Coronary arteries were segmented as suggested by the American
Heart Association.23 The right coronary artery was defined to
include segments 1–4, the left main artery and the left anterior des-
cending (LAD) artery to include segments 5–10, and the left circum-
flex artery (CX) to include segments 11–16; the intermediate artery
was designated as segment 16, if present. All segments with a diameter
of at least 1.5 mm at their origin were included. Two readers semi-
quantitatively assessed independently the overall image quality on a
four-point scale (1, excellent, no motion artefacts; 2, good, minor arte-
facts; 3, adequate, moderate artefacts; 4, non-evaluative, severe arte-
facts) as previously reported.14 Scores 1–3 were considered as
diagnostic, score 4 as non-diagnostic. Step artefacts at junctions of
different image blocks may not necessarily lead to misinterpretations.
However, as a hidden lesion within the artefact cannot be excluded
with absolute certainty, we have categorized any step artefact as
non-evaluative. Both readers assessed all coronary vessels for the pre-
sence of haemodynamically significant stenoses, defined as narrowing
of the coronary luminal diameter 50%. In case of multiple lesions
in one segment, the segment was classified by the worst lesion. For
any disagreement in data analysis between the two observers, consen-
sus agreement was achieved.
Invasive coronary angiography
Invasive CA was performed according to standard techniques, and
multiple views were stored on a CD-ROM. An experienced observer
blinded to the results from CTCA evaluated the angiograms. The cor-
onary arteries were subdivided according to the same model used for
the CT angiography images23 and were quantitatively assessed with the
use of an automated edge-detection system (Xcelera 1.2; Philips
Medical Systems, Best, the Netherlands) as reported previously.24 In
brief, quantitative CA measurements were performed in two image
planes and included the diameter of the reference vessel (proximal
and distal to the stenosis), the minimal luminal diameter, and the
extent of stenosis (defined as the diameter of the reference vessel
minus the minimal luminal diameter, divided by the reference diameter
and multiplied by 100%). For biplane assessment, diameters obtained in
both image planes were averaged. Coronary arteries were included in
the analysis if luminal diameter was at least 1.5 mm; excluding those
vessels distal to complete occlusions. Each vessel was scored as
being normal or significantly stenosed (defined as a diameter reduction
of 50%).
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Statistical analysis
Quantitative variables were expressed as mean+ standard deviation
and categorical variables as frequencies, median (25th, 75th percen-
tiles) or percentages.
Sensitivity, specificity, positive predictive value (PPV), and negative
predictive value (NPV) were calculated; invasive CA was considered
the standard of reference. The 95% confidence intervals (CI) were cal-
culated from binomial expression per vessel and per patient. We took
into account the clustered nature of the data (i.e. the fact that the 90
vessel were not independent but instead clusters of vessels in 30
patients). For these analyses, a proportion-procedure for survey data
of the Stata software (StataCorp 10.0, College Station, USA) with
patient as primary sample unit was performed to address dependen-
cies between the vessels.25
Results
Computed tomography coronary angiography and CA were suc-
cessfully performed in all 30 patients (19 males, 11 females, age
58.8+9.9 years) [median 2 days (0, 41)]. Twelve patients were
on beta-blocker therapy as part of their baseline medication.
Using CTCA, additional intravenous beta-blocker was adminis-
tered in 18 patients for HR control prior to CTCA (median
4.5 mg1,20 yielding a mean HR of 55.7+ 7.9 b.p.m. (range: 35–
70 b.p.m.) and a mean HR variability of 1.5+0.9 b.p.m. (range:
0.3–3.7 b.p.m.). The mean BMI was 27.0+ 4.9 kg/m2 (range:
21.9–42.5 kg/m2). The mean DLP was 125.8+ 43.1 mGy cm
(range: 58.3–192.7 mGy cm) resulting in an estimated mean effec-
tive radiation dose of 2.1+0.7 mSv (range: 1.0–3.3 mSv). Of the
480 theoretically possible segments in 30 patients with 16 coron-
ary segments, 52 were missing due to anatomical variants and 29
had a diameter of ,1.5 mm at their origin (by both methods).
Thus, 52 segments were missing for reasons not associated with
the methodology as these segments did simply not exist. The
remaining 29 segments were categorized as lower than 1.5 mm
and thus not evaluable by the gold standard invasive CA. Thus,
the missing data do not seem to introduce a selection bias.
Image quality with computed
tomography coronary angiography
Image quality of 383/399 segments (96.0%) in 26/30 patients was
diagnostic (score 1–3); excellent image quality (score 1) was
rated in 133 segments (33.3%), good (score 2) in 146 segments
(36.6%), and adequate (score 3) in 104 segments (26.1%).
Sixteen segments (4.0%) in four of 30 patients were non-diagnostic
(score 4) and were considered as false-positive. Two of these four
patients had correctly identified lesions in other segments,
re-categorizing these two as true positive patients. Table 1 shows
demographic data and overall image quality.
Diagnostic accuracy of computed
tomography coronary angiography
in comparison with invasive
coronary angiography
In 18 patients and 36 vessels, 66 coronary artery stenoses were
recognized with invasive CA. Single-vessel disease was present in
eight patients, two-vessel disease in two patients, and three-vessel
disease in eight patients. Figure 1 demonstrates an example of cor-
onary artery stenosis detection by CTCA and CA.
Low-dose CTCA correctly detected CAD in all patients (n ¼
18) and in all vessels (n ¼ 36) with lesions. Invasive CA revealed
no CAD in 12 patients. CAD has been correctly ruled out by
CTCA in 10 of 12 patients and in 48 of 54 vessels without coron-
ary stenoses. Two patients were categorized as false positive. Six
vessels were found to be false positive due to massive calcification
(n ¼ 2) or due to non-evaluative image quality caused by motion
artefacts (n ¼ 4). Of note, there was no false-negative finding,
neither per vessel nor per patient (Table 2).
On a per-vessel analysis, there was 100% (36/36) sensitivity,
88.9% (48/54, 95% CI: 0.77–1.00) specificity, 85.7% (36/42, 95%
CI: 0.70–1.00) PPV, and 100% (48/48) NPV.
On a per-patient analysis, there was 100% (18/18) sensitivity,
83.3% (10/12, 95% CI: 0.62–1.00) specificity, 90.0% (18/20, 95%
CI: 0.76–1.00) PPV, and 100% (10/10) NPV (Table 2).
Discussion
The present study is the first to demonstrate the accuracy
of low-dose CTCA using prospective ECG-triggering for the
assessment of CAD in comparison with the reference standard
invasive CA.
Radiation exposure to patients in CTCA has remained a source
of concern, even after successful reduction down to 9.4 mSv in
64-slice MDCT26 and to 7.8 mSv in dual source CT18 by applying
ECG-gated tube modulation and retrospective triggering. The
present protocol using prospective ECG-triggering allows to
further substantially reduce the effective radiation dose down to
2.1+ 0.7 mSv, which compares favourably to the average of
7 mSv typically reported for a diagnostic invasive CA.22 Our
results confirm the previously reported feasibility20 and document
a high accuracy of low-dose CTCA, comparing well to results from
retrospectively gating with 64-slice CT or dual-source CT.3–7,27,28
Interestingly, the NPV was excellent both on a per-patient and
on per-vessel base. This is important as the main strength and
the main clinical role of CTCA is thought to be exclusion of
Table 1 Patient demographics, overall image quality
Number of patients 30
Mean age+ SD (years) 58.8+9.9
Female/male 11/19
Mean BMI+ SD (kg/m2) 27.0+4.9
Mean HR+ SD (b.p.m.) 55.7+7.9
Mean HR variability+ SD (b.p.m.) 1.5+0.9
Mean effective radiation dose+ SD (mSv) 2.1+0.7
Overall image scorea 2.01+0.96
Score 1 (%) 33.3 (133/399)
Score 2 (%) 36.6 (146/399)
Score 3 (%) 26.1 (104/399)
Score 4 (%) 4.0 (16/399)
SD, standard deviation; HR heart rate; b.p.m., beats per minute.
aImage quality scores: 1, excellent; 2, good; 3, adequate; 4, not evaluative.
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CAD in low-to-intermediate probability populations.29 The
present study supports that low-dose CTCA can reliably rule
out CAD.
A criticism often raised against CTCA studies has been the
inclusion of high prevalence populations. This may also apply to
our study. However, validation of a new CTCA protocol for the
assessment of CAD requires comparison against the standard of
reference, namely invasive CA. The latter, however, is affected
by a small but distinct procedure-related morbidity (1.5%) and
mortality rate (0.15%),30 precluding its use for purely scientific pur-
poses in a low-probability population for ethical reasons. This may
introduce a bias as patients with normal CTCA findings would not
undergo invasive CA, which reduces true negative findings, result-
ing in an apparent decline in specificity.31 Therefore, we have
included only patients who were referred for invasive CA due to
clinical suspicion, which may explain the relatively high prevalence
of CAD in our study. This strengthens the validity of our results
with excellent NPV as in low-prevalence populations with more
true positive findings the NPV is generally higher.32
In addition, patient groups which we generally perceived as most
suitable for CTCA are typically younger and have less coronary
calcifications. This would improve image quality and reduce false-
positive findings. The large field of view in 256 or 320 multislice
CT scanners allows acquisition of the whole coronary tree
within one cardiac cycle eliminating any stair-step artefacts. Prelimi-
nary data confirm that the concept of prospective ECG triggering
is applicable in latest scanner generations. Thus, although prospec-
tive ECG-triggering is still in its infancies, this scanning protocol has
the potential to become a new standard.
We acknowledge the following limitation to our pilot study.
First, we included a relatively small number of only 30 patients.
Figure 1 Low-dose CT and invasive coronary angiography in a 42-year-old male patient with atypical chest pain. Right coronary artery (RCA),
left anterior descending artery (LAD) artery and circumflex artery (CX) illustrated as volume-rendered images, (A) maximum intensity projec-
tions, (B) invasive coronary angiography images, and (C) stretched multiplanar reconstructions. The arrow head indicates a non-calcified signifi-
cant stenosis in the proximal LAD.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Diagnostic accuracy
Patient based Vessel based
Stenoses in CA 18 36
Stenoses in CTCA 20 42
TP 18 36
FP 2 6
TN 10 48
FN 0 0
Sensitivity (%) 100 100
Specificity (%) (95% CI) 83.3 (0.62–1.00) 88.9 (0.77–1.00)
PPV (%) (95% CI) 90.0 (0.76–1.00) 85.7 (0.70–1.00)
NPV (%) 100 100
CA, coronary angiography; CTCA, CT coronary angiography; TP, true positives;
FP, false positives; TN, true negatives; FN, false negative; CI, confidence interval;
NPV, negative predictive value; PPV, positive predictive value.
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However, the results appear valid as we have used an
intention-to-diagnose strategy to achieve a clinically relevant end-
point, i.e. findings on a per-patient and per-vessel analysis. Further-
more, HR control is mandatory for prospective ECG triggering,20
explaining the frequent beta-blocker administration in this study,
though the median dose of 4.5 mg1,20 intravenous metoprolol in
our study compares well with previous reports.2–4,7,21,33 Never-
theless, as all patients turned out to have normal ejection fraction,
we may have introduced a bias towards lower heart rates and/or
eligibility for larger doses of intravenous metoprolol allowing to
reach the target heart rate of ,65 b.p.m. in each patient. Further-
more, by excluding patients with known coronary lesions, we may
have introduced a bias towards younger age. This may result in less
calcifications and also better ability to follow breath hold com-
mands. Finally, CTCA with prospective ECG-triggering does not
allow functional assessment of the left ventricle. This, however,
is generally assessed primarily with other modalities such as echo-
cardiography or a gated nuclear exam if hybrid imaging is
performed.34
In conclusion, prospective ECG-triggering allows to acquire
low-dose CTCA at radiation doses below those of invasive CA
providing high diagnostic accuracy in the assessment of CAD in
patients with stable sinus rhythm and a low heart rate.
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Giant Kawasaki coronary artery aneurysm: cardiac imaging evolution
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We present the evolution of cardiac imaging
findings in a female Caucasian teenager with a
diagnosis of Kawasaki’s disease since age
5. She had remained asymptomatic through-
out most of her life although stress myocar-
dial perfusion imaging had shown
myocardial ischaemia in the anterior and
anterior septal left ventricular wall (Panel A)
at age 11. Low-radiation dose 64-slice CT
coronary angiography (CTA) performed for
non-invasive disease surveillance at age 13
showed giant coronary artery aneurysms
(Panel B) in the proximal left anterior des-
cending coronary artery (LAD), as well as
in the proximal and mid-right coronary
artery (RCA), the two former of which
showed wall calcification and thrombus for-
mation, however, without flow-limiting ste-
nosis. Functional analysis based on cine-CT
reconstructions showed left ventricular func-
tion deficits in good correlation with prior
myocardial perfusion imaging. On the basis
of the CTA results, chronic anticoagulation
therapy was initiated. The patient started
developing a smoking habit at age 13. At
age 15, she complained about exertional ret-
rosternal pain. Echocardiography with Doppler flow evaluation of the coronary arteries was performed but deemed inconclusive due to
heavy vessel wall calcifications within the giant coronary aneurysms. Subsequently, ultra-low radiation dose dual-source coronary CTAwas
performed, which showed essentially unchanged appearance of the RCA aneurysms (Panels B–E). However, the LAD aneurysm showed
extensive progression of thrombus with interval near-complete occlusion (Panels C, G, and H ) and only faint contrast enhancement
of the LAD beyond the aneurysm. Invasive catheter angiography (Panels F and I) was subsequently performed with the intent of revascular-
ization,which confirmed the findings atCTAand showed extensive collateralizationof the LAD lesion.However, the nature of the lesionwas
deemed too complex for successful interventional revascularization, and an indication for surgical coronary artery bypass grafting was
established.
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